vs

Side-by-side financial comparison of Natera, Inc. (NTRA) and StoneX Group Inc. (SNEX). Click either name above to swap in a different company.

StoneX Group Inc. is the larger business by last-quarter revenue ($1.2B vs $665.5M, roughly 1.8× Natera, Inc.). StoneX Group Inc. runs the higher net margin — 11.6% vs 7.1%, a 4.5% gap on every dollar of revenue. On growth, StoneX Group Inc. posted the faster year-over-year revenue change (81.0% vs 39.8%). Natera, Inc. produced more free cash flow last quarter ($37.8M vs $-1.3B). Over the past eight quarters, StoneX Group Inc.'s revenue compounded faster (53.5% CAGR vs 34.5%).

Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA (cfDNA) testing technology, with a focus on women’s health, cancer, and organ health. Natera’s proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendment...

StoneX Group Inc. is an American financial services company. The company operates in six areas: commercial hedging, global payments, securities, physical commodities, foreign exchange and clearing and execution services (CES).

NTRA vs SNEX — Head-to-Head

Bigger by revenue
SNEX
SNEX
1.8× larger
SNEX
$1.2B
$665.5M
NTRA
Growing faster (revenue YoY)
SNEX
SNEX
+41.3% gap
SNEX
81.0%
39.8%
NTRA
Higher net margin
SNEX
SNEX
4.5% more per $
SNEX
11.6%
7.1%
NTRA
More free cash flow
NTRA
NTRA
$1.3B more FCF
NTRA
$37.8M
$-1.3B
SNEX
Faster 2-yr revenue CAGR
SNEX
SNEX
Annualised
SNEX
53.5%
34.5%
NTRA

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
NTRA
NTRA
SNEX
SNEX
Revenue
$665.5M
$1.2B
Net Profit
$47.3M
$139.0M
Gross Margin
Operating Margin
-3.4%
15.4%
Net Margin
7.1%
11.6%
Revenue YoY
39.8%
81.0%
Net Profit YoY
187.9%
63.3%
EPS (diluted)
$0.36
$2.50

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NTRA
NTRA
SNEX
SNEX
Q4 25
$665.5M
$1.2B
Q3 25
$592.2M
$32.7B
Q2 25
$546.6M
$851.2M
Q1 25
$501.8M
$820.4M
Q4 24
$476.1M
$663.1M
Q3 24
$439.8M
$31.1B
Q2 24
$413.4M
$571.8M
Q1 24
$367.7M
$509.2M
Net Profit
NTRA
NTRA
SNEX
SNEX
Q4 25
$47.3M
$139.0M
Q3 25
$-87.5M
$85.7M
Q2 25
$-100.9M
$63.4M
Q1 25
$-66.9M
$71.7M
Q4 24
$-53.8M
$85.1M
Q3 24
$-31.6M
$76.7M
Q2 24
$-37.5M
$61.9M
Q1 24
$-67.6M
$53.1M
Gross Margin
NTRA
NTRA
SNEX
SNEX
Q4 25
Q3 25
3.7%
Q2 25
Q1 25
Q4 24
Q3 24
3.0%
Q2 24
Q1 24
Operating Margin
NTRA
NTRA
SNEX
SNEX
Q4 25
-3.4%
15.4%
Q3 25
-16.5%
0.3%
Q2 25
-20.2%
-1.3%
Q1 25
-15.8%
-1.0%
Q4 24
-13.6%
-3.2%
Q3 24
-8.9%
-0.0%
Q2 24
-10.6%
-4.7%
Q1 24
-20.2%
-2.5%
Net Margin
NTRA
NTRA
SNEX
SNEX
Q4 25
7.1%
11.6%
Q3 25
-14.8%
0.3%
Q2 25
-18.5%
7.4%
Q1 25
-13.3%
8.7%
Q4 24
-11.3%
12.8%
Q3 24
-7.2%
0.2%
Q2 24
-9.1%
10.8%
Q1 24
-18.4%
10.4%
EPS (diluted)
NTRA
NTRA
SNEX
SNEX
Q4 25
$0.36
$2.50
Q3 25
$-0.64
$0.72
Q2 25
$-0.74
$1.22
Q1 25
$-0.50
$1.41
Q4 24
$-0.41
$1.69
Q3 24
$-0.26
$2.32
Q2 24
$-0.30
$1.25
Q1 24
$-0.56
$1.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NTRA
NTRA
SNEX
SNEX
Cash + ST InvestmentsLiquidity on hand
$1.6B
Total DebtLower is stronger
Stockholders' EquityBook value
$1.7B
$2.5B
Total Assets
$2.4B
$47.8B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NTRA
NTRA
SNEX
SNEX
Q4 25
$1.6B
Q3 25
$1.0M
$1.6B
Q2 25
$16.0M
$1.3B
Q1 25
$17.8M
$1.3B
Q4 24
$22.7M
$1.4B
Q3 24
$29.5M
$1.3B
Q2 24
$90.3M
$1.2B
Q1 24
$69.1M
$1.3B
Stockholders' Equity
NTRA
NTRA
SNEX
SNEX
Q4 25
$1.7B
$2.5B
Q3 25
$1.3B
$2.4B
Q2 25
$1.2B
$2.0B
Q1 25
$1.2B
$1.9B
Q4 24
$1.2B
$1.8B
Q3 24
$878.5M
$1.7B
Q2 24
$836.5M
$1.6B
Q1 24
$794.1M
$1.5B
Total Assets
NTRA
NTRA
SNEX
SNEX
Q4 25
$2.4B
$47.8B
Q3 25
$1.8B
$45.3B
Q2 25
$1.8B
$34.3B
Q1 25
$1.7B
$31.3B
Q4 24
$1.7B
$29.6B
Q3 24
$1.6B
$27.5B
Q2 24
$1.5B
$25.9B
Q1 24
$1.5B
$25.7B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NTRA
NTRA
SNEX
SNEX
Operating Cash FlowLast quarter
$73.9M
$-1.3B
Free Cash FlowOCF − Capex
$37.8M
$-1.3B
FCF MarginFCF / Revenue
5.7%
-106.4%
Capex IntensityCapex / Revenue
5.4%
1.3%
Cash ConversionOCF / Net Profit
1.56×
-9.08×
TTM Free Cash FlowTrailing 4 quarters
$109.1M
$3.5B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NTRA
NTRA
SNEX
SNEX
Q4 25
$73.9M
$-1.3B
Q3 25
$59.4M
$3.5B
Q2 25
$37.6M
$1.5B
Q1 25
$44.5M
$-154.5M
Q4 24
$52.9M
$-477.8M
Q3 24
$51.8M
$192.6M
Q2 24
$4.0M
$-622.1M
Q1 24
$27.0M
$784.0M
Free Cash Flow
NTRA
NTRA
SNEX
SNEX
Q4 25
$37.8M
$-1.3B
Q3 25
$37.0M
$3.5B
Q2 25
$11.7M
$1.5B
Q1 25
$22.6M
$-169.8M
Q4 24
$34.8M
$-491.4M
Q3 24
$35.5M
$175.9M
Q2 24
$-7.7M
$-640.5M
Q1 24
$6.7M
$766.6M
FCF Margin
NTRA
NTRA
SNEX
SNEX
Q4 25
5.7%
-106.4%
Q3 25
6.2%
10.7%
Q2 25
2.1%
173.3%
Q1 25
4.5%
-20.7%
Q4 24
7.3%
-74.1%
Q3 24
8.1%
0.6%
Q2 24
-1.9%
-112.0%
Q1 24
1.8%
150.5%
Capex Intensity
NTRA
NTRA
SNEX
SNEX
Q4 25
5.4%
1.3%
Q3 25
3.8%
0.1%
Q2 25
4.7%
1.9%
Q1 25
4.3%
1.9%
Q4 24
3.8%
2.1%
Q3 24
3.7%
0.1%
Q2 24
2.8%
3.2%
Q1 24
5.5%
3.4%
Cash Conversion
NTRA
NTRA
SNEX
SNEX
Q4 25
1.56×
-9.08×
Q3 25
41.18×
Q2 25
23.52×
Q1 25
-2.15×
Q4 24
-5.61×
Q3 24
2.51×
Q2 24
-10.05×
Q1 24
14.76×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons